Clinical Trial Update: Pembrolizumab in Muscle-invasive Bladder Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pembrolizumab for muscle-invasive bladder cancer and urothelial carcinoma is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer
• Urothelial Carcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Matthew Galsky | Conditions: Muscle Invasive Bladder Carcinoma, Localized Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING